Skip to content

The Value of bronchial washing fluid in EGFR mutation detection compared to histologic samples from lung cancer patients, a prospective multicenter blind study

The value of bronchial washing fluid in EGFR mutation detection from lung cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016001
Enrollment
Unknown
Registered
2018-05-05
Start date
2018-05-05
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Gold Standard:The molecular diagnosis results using histologic samples which establish the final diagnosis
Index test:The&#32
diagnostic&#32
results&#32
using&#32
washing&#32
samples

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with suspected peripheral lung cancers and undergo bronchoscopy for diagnosis; 2. Patients diagnosed with NSCLC and harboring EGFR sensitive mutations, undergo bronchoscopy for second biopsy after tumor progression after taking first/second generation of EGFR-TKIs; 3. Transbronchial lung biopsy (TBLB) was performed under the assistance of endobronchial ultrasound with guide sheath (EBUS-GS), and was evaluated as biopsy within or adjacent to targeted lesion by EBUS; 4. Patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. With endobronchial visible lesion; 2. Forceps failed to reach the targeted tumor lesion; 3. Endobronchial ultrasound probe was not applied; 4. Patients harboring EGFR wild type before taking EGFR-TKIs treatment; 5.Patients with contraindications for bronchoscopy or can not tolerate examination.

Design outcomes

Primary

MeasureTime frame
EGFR;

Secondary

MeasureTime frame
Other gene alterations;

Countries

China

Contacts

Public ContactXin Zhang

Zhongshan Hospital, Fudan University

zhang.xin@zs-hospital.sh.cn+86 13681975806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026